10-104143495-T-G
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBS1_SupportingBS2
The NM_025145.7(CFAP43):āc.4089A>Cā(p.Glu1363Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000932 in 1,614,112 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_025145.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CFAP43 | ENST00000357060.8 | c.4089A>C | p.Glu1363Asp | missense_variant | 32/38 | 1 | NM_025145.7 | ENSP00000349568.3 | ||
CFAP43 | ENST00000434629.5 | c.2082A>C | p.Glu694Asp | missense_variant | 17/23 | 1 | ENSP00000391364.1 | |||
CFAP43 | ENST00000457071.5 | c.633A>C | p.Glu211Asp | missense_variant | 6/12 | 2 | ENSP00000394274.1 |
Frequencies
GnomAD3 genomes AF: 0.000434 AC: 66AN: 152236Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000398 AC: 100AN: 251366Hom.: 0 AF XY: 0.000442 AC XY: 60AN XY: 135862
GnomAD4 exome AF: 0.000984 AC: 1438AN: 1461876Hom.: 3 Cov.: 31 AF XY: 0.000965 AC XY: 702AN XY: 727240
GnomAD4 genome AF: 0.000434 AC: 66AN: 152236Hom.: 0 Cov.: 32 AF XY: 0.000309 AC XY: 23AN XY: 74382
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 16, 2021 | The c.4089A>C (p.E1363D) alteration is located in exon 32 (coding exon 32) of the CFAP43 gene. This alteration results from a A to C substitution at nucleotide position 4089, causing the glutamic acid (E) at amino acid position 1363 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at